TI "Ozone Therapy: The Science Behind the Scandal" DT 940400 SO Longevity (04/94) Vol. 6, No. 5, P. 54 AB Ozone therapy, involving doses of the reactive oxygen gas, has long been in Europe a popular alternative treatment for a variety of ailments. While health authorities chide practitioners for using this "unproven" therapy, reports continue to describe favorable results. Scientists also continue to investigate the potential of ozone therapy to eliminate disease-causing organisms from the bloodstream. In the mid-1980s, German researchers began using a process called autohemotherapy to test the use of ozone on blood infected with HIV and hepatitis B and, in 1986, a biotech company called Medizone International was created to follow up on the approach. Since then, Canadian and American scientists have confirmed ozone's direct antiviral effects, and its ability to boost key parts of the immune system. Last May, a Canadian study reported that ozone completely inactivated SIV, the simian equivalent of HIV, in monkey blood. The implications for safeguarding the blood supply are clear, although the therapeutic potential is not. Nevertheless, according to Medizone, preliminary trials are being conducted at five centers in Italy using an ozone/oxygen mix to treat patients with HIV and hepatitis B. A great deal of research remains to be performed on ozone, but advocates predict that because ozone cannot be patented, it will not attract financial backing for the scientific studies needed to win FDA approval. Copyright (c) 1993 - Information, Inc., Bethesda, MD. This information is provided by the Centers for Disease Control & Prevention (CDC), National AIDS Clearinghouse as a public service. Non-profit reproduction is encouraged.